1 study found for:    SLC2A4
Show Display Options
Rank Status Study
1 Completed Ergocalciferol Therapy in Calcidiol Deficient, Hemodialysis Patients on Therapeutic Doses of Paricalcitol
Conditions: Inflammation;   Insulin Resistance
Interventions: Drug: Ergocalciferol;   Drug: Placebo

Indicates status has not been verified in more than two years